Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent

被引:83
作者
Mukhopadhyay, S [1 ]
Chapnick, BM [1 ]
Howlett, AC [1 ]
机构
[1] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2002年 / 282卷 / 06期
关键词
cannabinoid receptors; vanilloid receptors; pertussis toxin; endothelium; nitric oxide;
D O I
10.1152/ajpheart.00497.2001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The endogenous cannabinoid anandamide (arachidonylethanolamide) produces vasorelaxation in different vascular beds. In the present study, we found that anandamide and a metabolically stable analog, methanandamide, produced dose-dependent (10 nM-10 muM) vasorelaxation of similar to80% in a rabbit aortic ring preparation in an endothelium-dependent manner. Non-endothelium-dependent vasorelaxation was observed to be a maximum of 20-22% at >10 muM methanandamide. The efficacious CB1 receptor analogs desacetyllevonantradol (10 muM) and WIN55212-2 (10 muM) failed to produce vasorelaxation; however, the endothelium-dependent vasorelaxation evoked by methanandamide was partially (75%) blocked by the CB1 receptor antagonist SR141716A. The VR1 vanilloid receptor antagonist capsazepine or the calcitonin gene-related peptide (CGRP) antagonist CGRP-(8-37) partially attenuated (25%) the vasorelaxation in endothelium-intact preparations and greatly reduced the response in endothelium-denuded preparations. Pretreatment of aortic rings with N-G-nitro-L-arginine methyl ester completely blocked the methanandamide-, capsaicin-, and CGRP- induced vasorelaxation. Pretreatment of aortic rings with pertussis toxin attenuated the methanandamide-induced vasorelaxation in endothelium-intact aortic rings, indicating the involvement of G(i/o) proteins in the vasorelaxation; however, pertussis toxin treatment failed to block the endothelium-independent response. Thus, in the rabbit aorta, methanandamide- induced vasorelaxation exhibits two components: 1) in endothelium-intact rings, an SR141716A-sensitive, non-CB1 receptor component that requires pertussis toxin-sensitive G proteins and nitric oxide (NO) production; and 2) in endothelium-denuded rings, a component that is mediated by VR1 vanilloid receptors and possibly by the subsequent release of CGRP that requires NO production but is independent of pertussis toxin-sensitive G proteins.
引用
收藏
页码:H2046 / H2054
页数:9
相关论文
共 46 条
[31]   N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor [J].
Pratt, PF ;
Hillard, CJ ;
Edgemond, WS ;
Campbell, WB .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (01) :H375-H381
[32]   Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation [J].
Randall, MD ;
Kendall, DA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 335 (2-3) :205-209
[33]   An endogenous cannabinoid as an endothelium-derived vasorelaxant [J].
Randall, MD ;
Alexander, SPH ;
Bennett, T ;
Boyd, EA ;
Fry, JR ;
Gardiner, SM ;
Kemp, PA ;
McCulloch, AI ;
Kendall, DA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 229 (01) :114-120
[34]   Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery [J].
Randall, MD ;
McCulloch, AI ;
Kendall, DA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 333 (2-3) :191-197
[35]  
SAITO A, 1989, J PHARMACOL EXP THER, V248, P455
[36]   CGRP ENHANCES INDUCTION OF NO SYNTHASE IN VASCULAR SMOOTH-MUSCLE CELLS VIA A CAMP-DEPENDENT MECHANISM [J].
SCHINIKERTH, VB ;
FISSLTHALER, B ;
BUSSE, R .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1994, 267 (06) :H2483-H2490
[37]   Antagonism of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase [J].
Stefano, GB ;
Salzet, M ;
Magazine, HI ;
Bilfinger, TV .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (06) :813-820
[38]   NOVEL ANTAGONIST IMPLICATES THE CB1 CANNABINOID RECEPTOR IN THE HYPOTENSIVE ACTION OF ANANDAMIDE [J].
VARGA, K ;
LAKE, K ;
MARTIN, BR ;
KUNOS, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 278 (03) :279-283
[39]   Mechanism of the hypotensive action of anandamide in anesthetized rats [J].
Varga, K ;
Lake, KD ;
Huangfu, DH ;
Guyenet, PG ;
Kunos, G .
HYPERTENSION, 1996, 28 (04) :682-686
[40]   Cardiovascular actions of cannabinoids and their generation during shock [J].
Wagner, JA ;
Varga, K ;
Kunos, G .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (12) :824-836